- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03034434
Cervical Recuperation After Vaginal Delivery
July 24, 2020 updated by: ROY LAUTERBACH MD, Rambam Health Care Campus
Sonography Evaluation of Cervical Recuperation After Vaginal Delivery
Patients after vaginal delivery will undergo 3 trans-vaginal ultrasounds in order to examine the process of cervical recuperation post delivery.
Study Overview
Detailed Description
Patients after vaginal delivery will be recruited after receiving a full explanation and signing an informed consent.
The goal of the study is to examine cervical length after vaginal delivery at 3 different time intervals:
- 8 hours post delivery.
- 24 hours post delivery.
- 48 hours post delivery. At each interval a trans-vaginal ultrasound will be performed, evaluating cervical length. At the end of the 3rd and final ultrasound, the patient will finish her participation in the study/ Information regarding obstetric conditions such as labor induction, gestational age at the time of delivery etc. will be collected from patients' electronic files.
Study Type
Observational
Enrollment (Actual)
1384
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Haifa, Israel
- Rambam Health Care Campus
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 44 years (Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
Female
Sampling Method
Non-Probability Sample
Study Population
Patients after vaginal delivery.
Description
Inclusion Criteria:
- Any patient after vaginal delivery.
Exclusion Criteria:
- Any patient after cesarean section.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Patients after vaginal delivery
Patients after vaginal delivery willing to undergo 3 trans-vaginal ultrasounds within the 48 hours after delivery.
|
Three trans-vaginal ultrasounds, the 1st to be performed 8 hours post delivery, the 2nd 24 hours after delivery and the 3rd 48 hours after delivery.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Cervical length after vaginal delivery.
Time Frame: Up to 48 hours post delivery.
|
Measurement of cervical length 8, 24, 48 hours after vaginal delivery by trans-vaginal ultrasound.
|
Up to 48 hours post delivery.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Differences in cervical length after vaginal delivery.
Time Frame: Up to 48 hours post delivery.
|
Differences in cervical length after vaginal delivery as a factor of gestational age at delivery, means of labor induction, parity, etc.
|
Up to 48 hours post delivery.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 14, 2017
Primary Completion (Actual)
February 29, 2020
Study Completion (Actual)
June 30, 2020
Study Registration Dates
First Submitted
January 25, 2017
First Submitted That Met QC Criteria
January 26, 2017
First Posted (Estimate)
January 27, 2017
Study Record Updates
Last Update Posted (Actual)
July 27, 2020
Last Update Submitted That Met QC Criteria
July 24, 2020
Last Verified
July 1, 2020
More Information
Terms related to this study
Other Study ID Numbers
- 0154-16-RMB
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cervix
-
Pregnolia AGCompletedCervix; PregnancySwitzerland
-
Centre Hospitalier Universitaire, AmiensUnknownCervix; PregnancyFrance
-
St. Louis UniversityTerminated
-
Sohag UniversityRecruiting
-
Fatma Ahmed Abdelfatah RikabeSohag UniversityNot yet recruiting
-
Göteborg UniversityVastra Gotaland RegionRecruiting
-
University of VirginiaUnknownEducational Problems | Cervix, DysplasiaUnited States
-
Newish Technology (Beijing) Co., Ltd.Recruiting
-
All India Institute of Medical Sciences, New DelhiUnknownMetastatic Carcinoma to the Uterine Cervix | Recurrent Carcinoma Cervix | Cervix Carcinoma RecurrentIndia
Clinical Trials on Trans-vaginal ultrasound
-
Assiut UniversityNot yet recruitingOvarian Diseases
-
The University of Texas Health Science Center,...Recruiting
-
Cairo UniversityUnknown
-
Sheba Medical CenterCompleted
-
University Hospital, Basel, SwitzerlandCompleted
-
Kasr El Aini HospitalCompleted
-
Rambam Health Care CampusTerminated
-
Szeged UniversityUnknownUterine Prolapse | Urinary Stress Incontinence | Side EffectsHungary
-
Ain Shams UniversityCompletedFailed Induction | Cervical DystociaEgypt